Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Bovie Medical Corp (BVX)

Bovie Medical Corp (BVX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 215,136
  • Shares Outstanding, K 33,200
  • Annual Sales, $ 38,880 K
  • Annual Income, $ -5,060 K
  • 60-Month Beta -0.27
  • Price/Sales 5.47
  • Price/Cash Flow N/A
  • Price/Book 2.36
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.08
  • Most Recent Earnings -0.01 on 11/01/18
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.09
  • Number of Estimates 2
  • High Estimate -0.08
  • Low Estimate -0.10
  • Prior Year -0.03
  • Growth Rate Est. (year over year) -200.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.89 +32.52%
on 12/20/18
7.70 -15.84%
on 12/11/18
-0.59 (-8.35%)
since 11/30/18
3-Month
4.82 +34.44%
on 10/23/18
7.70 -15.84%
on 12/11/18
-0.62 (-8.73%)
since 09/28/18
52-Week
2.28 +184.21%
on 03/12/18
7.70 -15.84%
on 12/11/18
+3.88 (+149.23%)
since 12/29/17

Most Recent Stories

More News
Apyx Medical Corporation to Participate in the JMP Securities Life Sciences Conference

Apyx Medical Corporation, formerly Bovie Medical Corporation, (NASDAQ:APYX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented surgical...

APYX : 6.38 (-2.15%)
BVX : 6.48 (+1.09%)
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Apyx Medical Corporation To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Apyx Medical Corporation f/k/a Bovie Medical Corporation ("Apyx" or the "Company") (NASDAQ:APYX) of the June 17, 2019...

APYX : 6.38 (-2.15%)
BVX : 6.48 (+1.09%)
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Apyx Medical Corporation To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Apyx Medical Corporation f/k/a Bovie Medical Corporation ("Apyx" or the "Company") (NASDAQ:APYX) of the...

APYX : 6.38 (-2.15%)
BVX : 6.48 (+1.09%)
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Apyx Medical Corporation To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Apyx Medical Corporation f/k/a Bovie Medical Corporation ("Apyx" or the "Company") (NASDAQ:APYX) of the June 17, 2019...

APYX : 6.38 (-2.15%)
BVX : 6.48 (+1.09%)
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Apyx Medical Corporation To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Apyx Medical Corporation f/k/a Bovie Medical Corporation ("Apyx" or the "Company") (NASDAQ:APYX) of the...

APYX : 6.38 (-2.15%)
BVX : 6.48 (+1.09%)
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Apyx Medical Corporation To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Apyx Medical Corporation f/k/a Bovie Medical Corporation ("Apyx" or the "Company") (NASDAQ:APYX) of the June 17, 2019...

APYX : 6.38 (-2.15%)
BVX : 6.48 (+1.09%)
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Apyx Medical Corporation To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Apyx Medical Corporation f/k/a Bovie Medical Corporation ("Apyx" or the "Company") (NASDAQ:APYX) of the June 17, 2019...

APYX : 6.38 (-2.15%)
BVX : 6.48 (+1.09%)
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2019 Financial Results on May 8, 2019

Apyx Medical Corporation, formerly Bovie Medical Corporation, (NASDAQ:APYX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented surgical...

APYX : 6.38 (-2.15%)
BVX : 6.48 (+1.09%)
Global $198.5 Mn Cold Plasma Markets to 2026 Featuring US Medical Innovations, Bovie Medical, Neoplas Tools, Europlasma & P2i Limited

The "Cold Plasma Market Size, Share & Trends Analysis Report By Pressure (Atmospheric, Low-pressure Cold Plasma), By Application (Cancer Treatment, Wound Healing, Blood Coagulation), And Segment Forecasts,...

BVX : 6.48 (+1.09%)
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2018 Financial Results on March 13, 2019

Apyx Medical Corporation, formerly Bovie Medical Corporation, (NASDAQ:APYX) (the "Company"), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented surgical...

APYX : 6.38 (-2.15%)
BVX : 6.48 (+1.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade BVX with:

Business Summary

Bovie Medical Corporation, formerly An-Con Genetics Inc., is engaged in the manufacturing and marketing of a diverse line of medical devicesand advanced coating technologies.

See More

Key Turning Points

2nd Resistance Point 6.87
1st Resistance Point 6.68
Last Price 6.48
1st Support Level 6.32
2nd Support Level 6.15

See More

52-Week High 7.70
Last Price 6.48
Fibonacci 61.8% 5.63
Fibonacci 50% 4.99
Fibonacci 38.2% 4.35
52-Week Low 2.28

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar